Nath Bio-Genes (India) Limited (NATHBIOGEN)
Market Open
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
156. 17
-1.51
-0.9576%
₹
2.58B Market Cap
9.42 P/E Ratio
8% Div Yield
19,753 Volume
0 Eps
₹ 157.68
Previous Close Want to track NATHBIOGEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nath Bio-Genes (India) Limited (NATHBIOGEN) Statistics
Valuation metrics
Market Cap 2.58B
Enterprise value 3B
Trailing P/E (ttm) 8.56
Forward P/E -
PEG ratio -0.75
Price/Sales (ttm) 0.61
Price/Book (mrq) 0.44
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA 4.88
Overview
Shares outstanding 19M
Float 6.08M
Shares short -
% Held by insiders 0.64%
% Held by institutions -
Average volume (10 days) 35.18K
Average volume (90 days) 24.65K
Price summary
52-Week low 126.15
52-Week high 204
Beta 0.51
50-Day moving average 163.59
200-Day moving average 158.83
Dividends and splits
Forward annual dividend rate 8
Forward annual dividend yield 0.0614%
Trailing annual dividend rate 2
Trailing annual dividend yield 0.0127%
5-Year annual dividend yield -
Payout ratio 0.1
Dividend Date 21 Sep 2025
Ex-Dividend Date 14 Aug 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.08%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.06%
Income Statement
Revenue (ttm) 4.46B
Revenue per share (ttm) 257.74
Quarterly revenue growth (yoy) 0.79%
Gross profit (ttm) 3.18B
EBITDA 582.98M
Net income to common (ttm) 431.2M
Diluted EPS (ttm) 20.35
Quarterly earnings growth (yoy) -0.39%
Balance Sheet
Total cash (mrq) 7.42M
Total cash per share (mrq) 39.99
Total debt (mrq) 1.55B
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 1.97%
Book value per share (mrq) 358.06
Cash Flow
Cash flow statement -278.07M
Levered free cash flow (LFCF) 386M
